drugset / Trial / NCT01012375
Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to determine whether 2 weeks of treatment with AZD1446 compared to placebo improves ADHD symptoms and is well tolerated.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-08
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1446 | Small molecule | 10 mg | Oral |
| Subject | AZD1446 | Small molecule | 80 mg | Oral |